Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02033187 · ClinicalTrials.gov registry record · Phase 4
Daily Chlorhexidine Bathing and Infection Rates in Critically-ill Patients
A Phase 4 study, sponsored by Vanderbilt University.
- Completed
- Registry status
- Phase 4
- Development phase
- 12,000
- Enrollment target
NCT02033187 is a Phase 4 study that has completed, run by Vanderbilt University. The registered enrollment target is 12,000 participants.
The verdict
NCT02033187, a Phase 4 study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 12,000 participants
- Enrollment target
Study Summary
Healthcare-associated infections are a major cause of morbidity among critically ill patients. Bathing critically ill patients with cloths impregnated with the broad-spectrum antimicrobial agent chlorhexidine-gluconate may decrease healthcare-associated infections. The purpose of this study is to evaluate the effect of daily bathing with disposable chlorhexidine-impregnated bathing cloths, as compared to daily bathing with disposable standard non-chlorhexidine-impregnated bathing cloths, on the rates of healthcare-associated infections in critically-ill patients. Hypothesis: Daily bathing of the skin with chlorhexidine-impregnated bathing cloths will result in reduced rates of healthcare-associated infections in patients admitted to intensive care units (ICU).
Interventions
- OTHER Chlorhexidine bathing
- OTHER Non-chlorhexidine bathing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12,000 participants |
| Start Date | 2012-07 |
| Est. Completion | 2013-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02033187
The ClinicalTrials.gov registry entry for NCT02033187 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 12,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Chlorhexidine bathing is the first listed.
NCT02033187 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02033187 about?
NCT02033187 is a clinical study titled "Daily Chlorhexidine Bathing and Infection Rates in Critically-ill Patients". Healthcare-associated infections are a major cause of morbidity among critically ill patients. Bathing critically ill patients with cloths impregnated with the broad-spectrum antimicrobial agent chlorhexidine-gluconate may decrease healthcare-associated infections. The purpose of this study is to ev...
What is the current status of trial NCT02033187?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 12,000 participants. The study started on 2012-07. Estimated completion is 2013-07.
What interventions are being tested in trial NCT02033187?
The interventions under investigation include: Chlorhexidine bathing (OTHER), Non-chlorhexidine bathing (OTHER).
Who is sponsoring clinical trial NCT02033187?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.